Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis

SIMPLE SUMMARY: Acute myeloid leukemia (AML) with mutated RUNX1 (RUNX1(mut)) has an adverse prognosis based on the 2022 European LeukemiaNet risk stratification. However, the WHO classifications of 2022 removed RUNX1 mutations from the unique entity because of various prognoses and treatment outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Rungjirajittranon, Tarinee, Siriwannangkul, Theerapat, Kungwankiattichai, Smith, Leelakanok, Nattawut, Rotchanapanya, Wannaphorn, Vittayawacharin, Pongthep, Mekrakseree, Benjamaporn, Kulchutisin, Kamolchanok, Owattanapanich, Weerapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659296/
https://www.ncbi.nlm.nih.gov/pubmed/36358658
http://dx.doi.org/10.3390/cancers14215239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659296/
https://www.ncbi.nlm.nih.gov/pubmed/36358658
http://dx.doi.org/10.3390/cancers14215239

Ejemplares similares